Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Vultaggio

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Expert Opinion on Biological Therapy|October 31, 2022
Hypersensitivity reactions to biologics in childrenLeticia de Las Vecillas, Davide Caimmi, Ghislaine Annie Clarisse Isabwe, et al.
Rheumatology and Immunology Research|July 3, 2025
Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treatedGiulia Micheli, Lorenzo Salvati, Boaz Palterer, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature ReviewMarco Banini, Viola Salvestrini, Alessandra Vultaggio, et al.
The Journal of Infectious Diseases|June 29, 2002
Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasisMarie-Pierre Piccinni, Alessandra Vultaggio, Cristina Scaletti, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 24, 2008
Association between "sarcoidosis-like" disease and common variable immunodeficiency (CVI): a new CVI variant showing an activation of the immune systemAlessandra Vultaggio, Andrea Matucci, Paola Parronchi, et al.
Clinical Biochemistry|November 3, 2024
Quantitative evaluation of adalimumab and anti-adalimumab antibodies in sera using a surface plasmon resonance biosensorAndrea Di Santo, Matteo Accinno, Fosca Errante, et al.
Clinical Drug Investigation|September 8, 2018
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in ItalyRaffaella Viti, Andrea Marcellusi, Alessandro Capone, et al.
International Archives of Allergy and Immunology|December 28, 2006
Detection by flow cytometry of ESAT-6- and PPD-specific circulating CD4+ T lymphocytes as a diagnostic tool for tuberculosisLorenzo Cosmi, Laura Maggi, Veronica Santarlasci, et al.
European Journal of Immunology|September 26, 2018
Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRILaura Maggi, Beatrice Rossettini, Gianni Montaini, et al.
Clinical Drug Investigation|February 13, 2015
Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter studyAlessandra Vultaggio, Chiara Azzari, Cinzia Milito, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Expert Opinion on Biological Therapy|October 31, 2022
Hypersensitivity reactions to biologics in childrenLeticia de Las Vecillas, Davide Caimmi, Ghislaine Annie Clarisse Isabwe, et al.
Rheumatology and Immunology Research|July 3, 2025
Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treatedGiulia Micheli, Lorenzo Salvati, Boaz Palterer, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma: A Case Report and Literature ReviewMarco Banini, Viola Salvestrini, Alessandra Vultaggio, et al.
The Journal of Infectious Diseases|June 29, 2002
Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasisMarie-Pierre Piccinni, Alessandra Vultaggio, Cristina Scaletti, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 24, 2008
Association between "sarcoidosis-like" disease and common variable immunodeficiency (CVI): a new CVI variant showing an activation of the immune systemAlessandra Vultaggio, Andrea Matucci, Paola Parronchi, et al.
Clinical Biochemistry|November 3, 2024
Quantitative evaluation of adalimumab and anti-adalimumab antibodies in sera using a surface plasmon resonance biosensorAndrea Di Santo, Matteo Accinno, Fosca Errante, et al.
Clinical Drug Investigation|September 8, 2018
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in ItalyRaffaella Viti, Andrea Marcellusi, Alessandro Capone, et al.
International Archives of Allergy and Immunology|December 28, 2006
Detection by flow cytometry of ESAT-6- and PPD-specific circulating CD4+ T lymphocytes as a diagnostic tool for tuberculosisLorenzo Cosmi, Laura Maggi, Veronica Santarlasci, et al.
European Journal of Immunology|September 26, 2018
Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRILaura Maggi, Beatrice Rossettini, Gianni Montaini, et al.
Clinical Drug Investigation|February 13, 2015
Subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency in routine clinical practice: the VISPO prospective multicenter studyAlessandra Vultaggio, Chiara Azzari, Cinzia Milito, et al.
Pageof 14